Keith Olson

University of Michigan, Ann Arbor, Ann Arbor, MI 
"Keith Olson"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Olson KM, Devereaux AL, Chatterjee P, et al. (2023) Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy. Frontiers in Pharmacology. 14: 1230053
Olson KM, Hillhouse TM, Burgess GE, et al. (2022) Delta opioid receptor-mediated antidepressant-like effects of diprenorphine in mice. The Journal of Pharmacology and Experimental Therapeutics
Disney A, Olson KM, Shafer AM, et al. (2022) Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose. Acs Chemical Neuroscience
Olson KM, Campbell A, Alt A, et al. (2022) Finding the Perfect Fit: Conformational Biosensors to Determine the Efficacy of GPCR Ligands. Acs Pharmacology & Translational Science. 5: 694-709
Gerak LR, Maguire DR, Cami-Kobeci G, et al. (2022) OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects. Behavioural Pharmacology. 33: 377-394
Chan WKB, Olson KM, Wotring JW, et al. (2022) In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs. Scientific Reports. 12: 5320
Olson KM, Traynor JR, Alt A. (2021) Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators. Frontiers in Chemistry. 9: 671483
Keresztes A, Olson K, Nguyen P, et al. (2021) Antagonism of the Mu-Delta Opioid Receptor Heterodimer Enhances Opioid Anti-Nociception by Activating Src and CaMKII Signaling. Pain
Hillhouse TM, Olson K, Hallahan JE, et al. (2021) The Journal of Pharmacology and Experimental Therapeutics
Olson KM, Hillhouse TE, Sears BF, et al. (2020) Buprenorphine Analogs to Treat Relapse The Faseb Journal. 34: 1-1
See more...